Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation? (original) (raw)

• Adli M, Hollinde DL, Stamm T, Wiethoff K, Tsahuridu M, Kirchheiner J et al (2007). Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol Psychiatry 62: 1295–1302.
  CAS PubMed Google Scholar
• Alimohamad H, Rajakumar N, Seah YH, Rushlow W (2005). Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum. Biol Psychiatry 57: 533–542.
  CAS PubMed Google Scholar
• Aubry JM, Schwald M, Ballmann E, Karege F (2009). Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation. Psychopharmacology (Berl) 205: 419–429.
  CAS Google Scholar
• Beaulieu JM, Marion S, Rodriguiz RM, Medvedev IO, Sotnikova TD, Ghisi V et al (2008a). A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132: 125–136.
  CAS PubMed Google Scholar
• Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG (2005). An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261–273.
  CAS PubMed Google Scholar
• Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR et al (2004). Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099–5104.
  Article CAS PubMed PubMed Central Google Scholar
• Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC et al (2008b). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105: 1333–1338.
  CAS PubMed PubMed Central Google Scholar
• Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R et al (1998). Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596–599.
  CAS PubMed Google Scholar
• Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C et al (2004a). A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355: 37–40.
  CAS PubMed Google Scholar
• Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E (2004b). A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368: 123–126.
  CAS PubMed Google Scholar
• Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C et al (2005). Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci Lett 376: 51–55.
  CAS PubMed Google Scholar
• Bersudsky Y, Shaldubina A, Kozlovsky N, Woodgett JR, Agam G, Belmaker RH (2008). Glycogen synthase kinase-3beta heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results. Behav Pharmacol 19: 217–224.
  CAS PubMed Google Scholar
• Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ et al (2006). Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311: 864–868.
  CAS PubMed Google Scholar
• Beurel E, Jope RS (2006). The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 79: 173–189.
  CAS PubMed PubMed Central Google Scholar
• Beurel E, Jope RS (2009). Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J Neuroinflammation 6: 9.
  PubMed PubMed Central Google Scholar
• Bijur GN, Jope RS (2000). Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem 75: 2401–2408.
  CAS PubMed Google Scholar
• Bullock BP, Habener JF (1998). Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge. Biochemistry 37: 3795–3809.
  CAS PubMed Google Scholar
• Carlezon Jr WA, Duman RS, Nestler EJ (2005). The many faces of CREB. Trends Neurosci 28: 436–445.
  CAS PubMed Google Scholar
• Chalecka-Franaszek E, Chuang DM (1999). Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci USA 96: 8745–8750.
  CAS PubMed PubMed Central Google Scholar
• Chen AC, Shirayama Y, Shin KH, Neve RL, Duman RS (2001). Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49: 753–762.
  CAS PubMed Google Scholar
• Chen B, Wang JF, Hill BC, Young LT (1999a). Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos. Brain Res Mol Brain Res 70: 45–53.
  CAS PubMed Google Scholar
• Chen G, Huang LD, Jiang YM, Manji HK (1999b). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 72: 1327–1330.
  CAS PubMed Google Scholar
• Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK (2000). Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75: 1729–1734.
  CAS PubMed Google Scholar
• Chen L, Salinas GD, Li X (2009). Regulation of serotonin 1B receptor by glycogen synthase kinase-3. Mol Pharmacol 76: 1150–1161.
  CAS PubMed PubMed Central Google Scholar
• Chu B, Soncin F, Price BD, Stevenson MA, Calderwood SK (1996). Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J Biol Chem 271: 30847–30857.
  CAS PubMed Google Scholar
• Chuang DM (2005). The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann NY Acad Sci 1053: 195–204.
  CAS PubMed Google Scholar
• Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ, Millar JK (2008). The DISC locus in psychiatric illness. Mol Psychiatry 13: 36–64.
  CAS PubMed Google Scholar
• Citri A, Malenka RC (2008). Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology 33: 18–41.
  PubMed Google Scholar
• Cohen P, Goedert M (2004). GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3: 479–487.
  CAS PubMed Google Scholar
• Cole A, Frame S, Cohen P (2004). Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J 377: 249–255.
  CAS PubMed PubMed Central Google Scholar
• Cousins DA, Butts K, Young AH (2009). The role of dopamine in bipolar disorder. Bipolar Disord 11: 787–806.
  CAS PubMed Google Scholar
• Cowen DS, Johnson-Farley NN, Travkina T (2005). 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons. J Neurochem 93: 910–917.
  CAS PubMed PubMed Central Google Scholar
• Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785–789.
  CAS PubMed Google Scholar
• Dantzer R, Kelley KW (2007). Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21: 153–160.
  CAS PubMed Google Scholar
• Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46–56.
  CAS PubMed PubMed Central Google Scholar
• David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I et al (2009). Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62: 479–493.
  CAS PubMed PubMed Central Google Scholar
• Davies G, Jiang WG, Mason MD (2001). The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer. Int J Oncol 18: 843–847.
  CAS PubMed Google Scholar
• De Sarno P, Li X, Jope RS (2002). Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43: 1158–1164.
  CAS PubMed Google Scholar
• Derry S, Moore RA (2007). Atypical antipsychotics in bipolar disorder: systematic review of randomised trials. BMC Psychiatry 7: 40.
  PubMed PubMed Central Google Scholar
• Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR (2007). Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev Cell 12: 957–971.
  CAS PubMed PubMed Central Google Scholar
• Doble BW, Woodgett JR (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116 (Part 7): 1175–1186.
  CAS PubMed Google Scholar
• Dranovsky A, Hen R (2006). Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 59: 1136–1143.
  CAS PubMed PubMed Central Google Scholar
• Duman RS (2004). Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med 5: 11–25.
  CAS PubMed Google Scholar
• Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597–606.
  CAS PubMed Google Scholar
• Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116–1127.
  CAS PubMed Google Scholar
• Eickholt BJ, Towers GJ, Ryves WJ, Eikel D, Adley K, Ylinen LM et al (2005). Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol Pharmacol 67: 1426–1433.
  CAS PubMed Google Scholar
• Embi N, Rylatt DB, Cohen P (1980). Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 107: 519–527.
  CAS PubMed Google Scholar
• Eom TY, Jope RS (2009). Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3alpha/beta impairs in vivo neural precursor cell proliferation. Biol Psychiatry 66: 494–502.
  CAS PubMed PubMed Central Google Scholar
• Fang X, Yu SX, Lu Y, Bast Jr RC, Woodgett JR, Mills GB (2000). Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97: 11960–11965.
  CAS PubMed PubMed Central Google Scholar
• Fiol CJ, Williams JS, Chou CH, Wang QM, Roach PJ, Andrisani OM (1994). A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase- 3 in the control of gene expression. J Biol Chem 269: 32187–32193.
  CAS PubMed Google Scholar
• Force T, Woodgett JR (2009). Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development. J Biol Chem 284: 9643–9647.
  CAS PubMed PubMed Central Google Scholar
• Frame S, Cohen P (2001). GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359 (Part 1): 1–16.
  CAS PubMed PubMed Central Google Scholar
• Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S (2001). Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158: 100–106.
  CAS Google Scholar
• Goode N, Hughes K, Woodgett JR, Parker PJ (1992). Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 267: 16878–16882.
  CAS PubMed Google Scholar
• Goold RG, Owen R, Gordon-Weeks PR (1999). Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J Cell Sci 112 (Part 19): 3373–3384.
  CAS PubMed Google Scholar
• Gould TD, Einat H, Bhat R, Manji HK (2004). AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7: 387–390.
  CAS PubMed Google Scholar
• Gould TD, Einat H, O’Donnell KC, Picchini AM, Schloesser RJ, Manji HK (2007). Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 32: 2173–2183.
  CAS PubMed Google Scholar
• Gould TD, O’Donnell KC, Picchini AM, Dow ER, Chen G, Manji HK (2008). Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice. Behav Brain Res 189: 117–125.
  CAS PubMed PubMed Central Google Scholar
• Grimes CA, Jope RS (2001). CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78: 1219–1232.
  CAS PubMed PubMed Central Google Scholar
• Gurvich N, Klein PS (2002). Lithium and valproic acid: parallels and contrasts in diverse signaling contexts. Pharmacol Ther 96: 45–66.
  CAS PubMed Google Scholar
• Hall AC, Brennan A, Goold RG, Cleverley K, Lucas FR, Gordon-Weeks PR et al (2002). Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 20: 257–270.
  CAS PubMed Google Scholar
• Hartigan JA, Xiong WC, Johnson GV (2001). Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2. Biochem Biophys Res Commun 284: 485–489.
  CAS PubMed Google Scholar
• Hashimoto R, Senatorov V, Kanai H, Leeds P, Chuang DM (2003). Lithium stimulates progenitor proliferation in cultured brain neurons. Neuroscience 117: 55–61.
  CAS PubMed Google Scholar
• Hayley S, Poulter MO, Merali Z, Anisman H (2005). The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135: 659–678.
  CAS PubMed Google Scholar
• Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS (1997). Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Dev Biol 185: 82–91.
  CAS PubMed Google Scholar
• Henderson BR (2000). Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol 2: 653–660.
  CAS PubMed Google Scholar
• Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR (2000). Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406: 86–90.
  CAS PubMed Google Scholar
• Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT et al (2006). IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563–574.
  CAS PubMed Google Scholar
• Hughes K, Nikolakaki E, Plyte SE, Totty NF, Woodgett JR (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. Embo J 12: 803–808.
  CAS PubMed PubMed Central Google Scholar
• Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P et al (2009). Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 66: 721–728.
  CAS PubMed Google Scholar
• Jans LA, Riedel WJ, Markus CR, Blokland A (2007). Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12: 522–543.
  CAS PubMed Google Scholar
• Januel D, Massot O, Poirier MF, Olie JP, Fillion G (2002). Interaction of lithium with 5-HT(1B) receptors in depressed unipolar patients treated with clomipramine and lithium vs clomipramine and placebo: preliminary results. Psychiatry Res 111: 117–124.
  CAS PubMed Google Scholar
• Jin N, Kovacs AD, Sui Z, Dewhurst S, Maggirwar SB (2005). Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death. Neuropharmacology 48: 576–583.
  CAS PubMed Google Scholar
• Johnson-Farley NN, Travkina T, Cowen DS (2006). Cumulative activation of akt and consequent inhibition of glycogen synthase kinase-3 by brain-derived neurotrophic factor and insulin-like growth factor-1 in cultured hippocampal neurons. J Pharmacol Exp Ther 316: 1062–1069.
  CAS PubMed Google Scholar
• Jope RS, Johnson GVW (2004). The glamour and gloom of glycogen synthase kinase-3. Trehds in Biochemical Sci 29: 95–102.
  CAS Google Scholar
• Kaidanovich-Beilin O, Lipina TV, Takao K, van Eede M, Hattori S, Laliberte C et al (2009). Abnormalities in brain structure and behavior in GSK-3alpha mutant mice. Mol Brain 2: 35.
  PubMed PubMed Central Google Scholar
• Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004). Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55: 781–784.
  CAS PubMed Google Scholar
• Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS (2004). The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett 560: 115–119.
  CAS PubMed Google Scholar
• Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R et al (2007). Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61: 240–245.
  CAS PubMed Google Scholar
• Kim AJ, Shi Y, Austin RC, Werstuck GH (2005). Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci 118 (Part 1): 89–99.
  CAS PubMed Google Scholar
• Kim NR, Park SW, Lee JG, Kim YH (2008). Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells. Prog Neuropsychopharmacol Biol Psychiatry 32: 633–642.
  CAS PubMed Google Scholar
• Kim WY, Wang X, Wu Y, Doble BW, Patel S, Woodgett JR et al (2009). GSK-3 is a master regulator of neural progenitor homeostasis. Nat Neurosci 12: 1390–1397.
  CAS PubMed PubMed Central Google Scholar
• Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455–8459.
  CAS PubMed PubMed Central Google Scholar
• Kockeritz L, Doble B, Patel S, Woodgett JR (2006). Glycogen synthase kinase-3—an overview of an over-achieving protein kinase. Curr Drug Targets 7: 1377–1388.
  CAS PubMed Google Scholar
• Kozlovsky N, Amar S, Belmaker RH, Agam G (2006). Psychotropic drugs affect Ser9-phosphorylated GSK-3beta protein levels in rodent frontal cortex. Int J Neuropsychopharmacol 9: 337–342.
  CAS PubMed Google Scholar
• Kozlovsky N, Belmaker RH, Agam G (2000). Low GSK-3beta immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 157: 831–833.
  CAS PubMed Google Scholar
• Lamarre M, Desrosiers RR (2008). Up-regulation of protein l-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization. Neuropharmacology 55: 669–676.
  CAS PubMed Google Scholar
• Lesort M, Greendorfer A, Stockmeier C, Johnson GV, Jope RS (1999a). Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. J Neural Transm 106: 1217–1222.
  CAS PubMed Google Scholar
• Lesort M, Jope RS, Johnson GV (1999b). Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem 72: 576–584.
  CAS PubMed Google Scholar
• Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA (2000). Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol 20: 9356–9363.
  CAS PubMed PubMed Central Google Scholar
• Li X, Friedman AB, Roh MS, Jope RS (2005). Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain. J Neurochem 92: 701–704.
  PubMed PubMed Central Google Scholar
• Li X, Friedman AB, Zhu W, Wang L, Boswell S, May RS et al (2007a). Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Biol Psychiatry 61: 216–222.
  CAS PubMed Google Scholar
• Li X, Rosborough KM, Friedman AB, Zhu W, Roth KA (2007b). Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int J Neuropsychopharmacol 10: 7–19.
  PubMed Google Scholar
• Li X, Zhu W, Roh MS, Friedman AB, Rosborough K, Jope RS (2004). In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain. Neuropsychopharmacology 29: 1426–1431.
  CAS PubMed Google Scholar
• Liang MH, Chuang DM (2006). Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J Biol Chem 281: 30479–30484.
  CAS PubMed Google Scholar
• Liang MH, Chuang DM (2007). Regulation and function of glycogen synthase kinase-3 isoforms in neuronal survival. J Biol Chem 282: 3904–3917.
  CAS PubMed Google Scholar
• Lie DC, Song H, Colamarino SA, Ming GL, Gage FH (2004). Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44: 399–421.
  CAS PubMed Google Scholar
• Lotrich FE, Ferrell RE, Rabinovitz M, Pollock BG (2009). Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry 65: 344–348.
  CAS PubMed Google Scholar
• Lucas JJ, Hernandez F, Gomez-Ramos P, Moran MA, Hen R, Avila J (2001). Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. Embo J 20: 27–39.
  CAS PubMed PubMed Central Google Scholar
• Machado-Vieira R, Manji HK, Zarate Jr CA (2009). The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11 (Suppl 2): 92–109.
  CAS PubMed PubMed Central Google Scholar
• Maggio N, Segal M (2009). Differential modulation of long-term depression by acute stress in the rat dorsal and ventral hippocampus. J Neurosci 29: 8633–8638.
  CAS PubMed PubMed Central Google Scholar
• Mai L, Jope RS, Li X (2002). BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J Neurochem 82: 75–83.
  CAS PubMed Google Scholar
• Malberg JE, Duman RS (2003). Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28: 1562–1571.
  CAS PubMed Google Scholar
• Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104–9110.
  CAS PubMed PubMed Central Google Scholar
• Manev H, Uz T, Smalheiser NR, Manev R (2001). Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol 411: 67–70.
  CAS PubMed Google Scholar
• Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK et al (2009). Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136: 1017–1031.
  CAS PubMed PubMed Central Google Scholar
• Martin M, Rehani K, Jope RS, Michalek SM (2005). Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6: 777–784.
  CAS PubMed PubMed Central Google Scholar
• Martinez A, Castro A, Medina M (2006). Glycogen Synthase Kinase 3 (GSK-3) and its Inhibitors. John Wiley and Sons: Hoboken, NJ.
  Google Scholar
• Massot O, Rousselle JC, Fillion MP, Januel D, Plantefol M, Fillion G (1999). 5-HT1B receptors: a novel target for lithium. Possible involvement in mood disorders. Neuropsychopharmacology 21: 530–541.
  CAS PubMed Google Scholar
• McEwen BS (2008). Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol 583: 174–185.
  CAS PubMed PubMed Central Google Scholar
• McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R et al (2005). Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. Embo J 24: 1571–1583.
  CAS PubMed PubMed Central Google Scholar
• Meijer L, Flajolet M, Greengard P (2004). Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25: 471–480.
  CAS PubMed Google Scholar
• Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al (2000). Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9: 1415–1423.
  CAS PubMed Google Scholar
• Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732–741.
  CAS PubMed PubMed Central Google Scholar
• Mohammad MK, Al-Masri IM, Taha MO, Al-Ghussein MA, Alkhatib HS, Najjar S et al (2008). Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation. Eur J Pharmacol 584: 185–191.
  CAS PubMed Google Scholar
• Nibuya M, Nestler EJ, Duman RS (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16: 2365–2372.
  CAS PubMed PubMed Central Google Scholar
• O’Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG (2007). Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41: 326–331.
  PubMed Google Scholar
• O’Brien SM, Scully P, Scott LV, Dinan TG (2006). Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 90: 263–267.
  PubMed Google Scholar
• O’Brien WT, Harper AD, Jove F, Woodgett JR, Maretto S, Piccolo S et al (2004). Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 24: 6791–6798.
  PubMed PubMed Central Google Scholar
• O’Brien WT, Klein PS (2009). Validating GSK3 as an in vivo target of lithium action. Biochem Soc Trans 37 (Part 5): 1133–1138.
  PubMed PubMed Central Google Scholar
• Ozaki N, Chuang DM (1997). Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 69: 2336–2344.
  CAS PubMed Google Scholar
• Pandey GN, Ren X, Rizavi HS, Dwivedi Y (2010). Glycogen synthase kinase-3beta in the platelets of patients with mood disorders: effect of treatment. J Psychiatr Res 44: 143–148.
  PubMed Google Scholar
• Papkoff J, Aikawa M (1998). WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun 247: 851–858.
  CAS PubMed Google Scholar
• Park HJ, Cui FJ, Hwang JY, Kang UG (2010). Effects of clozapine on behavioral sensitization induced by cocaine. Psychiatry Res 175: 165–170.
  CAS PubMed Google Scholar
• Park SW, Lee JG, Ha EK, Choi SM, Cho HY, Seo MK et al (2009). Differential effects of aripiprazole and haloperidol on BDNF-mediated signal changes in SH-SY5Y cells. Eur Neuropsychopharmacol 19: 356–362.
  CAS PubMed Google Scholar
• Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J et al (2007). LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53: 703–717.
  CAS PubMed Google Scholar
• Phiel CJ, Wilson CA, Lee VM, Klein PS (2003). GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 423: 435–439.
  CAS PubMed Google Scholar
• Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001). Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734–36741.
  CAS PubMed Google Scholar
• Philip NS, Carpenter LL, Tyrka AR, Price LH (2008). Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J Psychiatr Pract 14: 34–44.
  PubMed Google Scholar
• Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA et al (2009). Forkhead box, class o transcription factors in brain: regulation and behavioral manifestation. Biol Psychiatry 65: 150–159.
  CAS PubMed Google Scholar
• Polter AM, Beurel E, Yang S, Garner R, Song L, Miller CA et al (2010). Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Neuropsychopharmacology 35: 1761–1774.
  CAS PubMed PubMed Central Google Scholar
• Post RM (2007). Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J Psychiatr Res 41: 979–990.
  PubMed Google Scholar
• Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I et al (2006). Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 26: 9022–9029.
  CAS PubMed PubMed Central Google Scholar
• Quiroz JA, Gould TD, Manji HK (2004). Molecular effects of lithium. Mol Interv 4: 259–272.
  CAS PubMed Google Scholar
• Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24–31.
  CAS PubMed Google Scholar
• Rao JS, Lee HJ, Rapoport SI, Bazinet RP (2008). Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol Psychiatry 13: 585–596.
  CAS PubMed Google Scholar
• Redrobe JP, Bourin M (1999). Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology (Berl) 141: 370–377.
  CAS Google Scholar
• Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445–452.
  CAS PubMed Google Scholar
• Ren M, Senatorov VV, Chen RW, Chuang DM (2003). Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci USA 100: 6210–6215.
  CAS PubMed PubMed Central Google Scholar
• Riad M, Garcia S, Watkins KC, Jodoin N, Doucet E, Langlois X et al (2000). Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol 417: 181–194.
  CAS PubMed Google Scholar
• Rivest S (2009). Regulation of innate immune responses in the brain. Nat Rev Immunol 9: 429–439.
  CAS PubMed Google Scholar
• Roh MS, Eom TY, Zmijewska AA, De Sarno P, Roth KA, Jope RS (2005). Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Biol Psychiatry 57: 278–286.
  CAS PubMed Google Scholar
• Roh MS, Seo MS, Kim Y, Kim SH, Jeon WJ, Ahn YM et al (2007). Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex. Exp Mol Med 39: 353–360.
  CAS PubMed Google Scholar
• Rosa AO, Kaster MP, Binfare RW, Morales S, Martin-Aparicio E, Navarro-Rico ML et al (2008). Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry 32: 1549–1556.
  CAS PubMed Google Scholar
• Roumestan C, Michel A, Bichon F, Portet K, Detoc M, Henriquet C et al (2007). Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 8: 35.
  PubMed PubMed Central Google Scholar
• Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996). Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272: 1023–1026.
  CAS PubMed Google Scholar
• Ryves WJ, Dalton EC, Harwood AJ, Williams RS (2005). GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disord 7: 260–265.
  CAS PubMed Central Google Scholar
• Ryves WJ, Harwood AJ (2001). Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280: 720–725.
  CAS PubMed Google Scholar
• Salinas PC (1999). Wnt factors in axonal remodelling and synaptogenesis. Biochem Soc Symp 65: 101–109.
  CAS PubMed Google Scholar
• Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805–809.
  CAS PubMed Google Scholar
• Sari Y (2004). Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 28: 565–582.
  CAS PubMed Google Scholar
• Schloesser RJ, Huang J, Klein PS, Manji HK (2008). Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33: 110–133.
  CAS PubMed Google Scholar
• Schmid CL, Raehal KM, Bohn LM (2008). Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc Natl Acad Sci USA 105: 1079–1084.
  CAS PubMed PubMed Central Google Scholar
• Schmidt HD, Duman RS (2007). The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18: 391–418.
  CAS PubMed Google Scholar
• Schotte A, Bonaventure P, Janssen PF, Leysen JE (1995). In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. Jpn J Pharmacol 69: 399–412.
  CAS PubMed Google Scholar
• Shaltiel G, Chen G, Manji HK (2007). Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 7: 22–26.
  CAS PubMed Google Scholar
• Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leao P et al (2008). Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 152: 656–669.
  CAS PubMed Google Scholar
• Song L, De Sarno P, Jope RS (2002). Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J Biol Chem 277: 44701–44708.
  CAS PubMed Google Scholar
• Spittaels K, Van den Haute C, Van Dorpe J, Geerts H, Mercken M, Bruynseels K et al (2000). Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. J Biol Chem 275: 41340–41349.
  CAS PubMed Google Scholar
• Spittaels K, Van den Haute C, Van Dorpe J, Terwel D, Vandezande K, Lasrado R et al (2002). Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience 113: 797–808.
  CAS PubMed Google Scholar
• St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G et al (1990). Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336: 13–16.
  CAS PubMed Google Scholar
• Stambolic V, Ruel L, Woodgett JR (1996). Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6: 1664–1668.
  CAS PubMed Google Scholar
• Stambolic V, Woodgett JR (1994). Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem J 303 (Part 3): 701–704.
  CAS PubMed PubMed Central Google Scholar
• Sutherland C, Cohen P (1994). The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett 338: 37–42.
  CAS PubMed Google Scholar
• Sutherland C, Leighton IA, Cohen P (1993). Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296 (Part 1): 15–19.
  CAS PubMed PubMed Central Google Scholar
• Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M et al (2006). Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 7: 158–161.
  PubMed Google Scholar
• Takahashi-Yanaga F, Shiraishi F, Hirata M, Miwa Y, Morimoto S, Sasaguri T (2004). Glycogen synthase kinase-3beta is tyrosine-phosphorylated by MEK1 in human skin fibroblasts. Biochem Biophys Res Commun 316: 411–415.
  CAS PubMed Google Scholar
• Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S et al (2000). cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20: 4030–4036.
  CAS PubMed PubMed Central Google Scholar
• Thornton TM, Pedraza-Alva G, Deng B, Wood CD, Aronshtam A, Clements JL et al (2008). Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation. Science 320: 667–670.
  CAS PubMed PubMed Central Google Scholar
• Toledo EM, Colombres M, Inestrosa NC (2008). Wnt signaling in neuroprotection and stem cell differentiation. Prog Neurobiol 86: 281–296.
  CAS PubMed Google Scholar
• Tsai SJ, Liou YJ, Hong CJ, Yu YW, Chen TJ (2008). Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. Pharmacogenomics J 8: 384–390.
  CAS PubMed Google Scholar
• Wang QM, Park IK, Fiol CJ, Roach PJ, DePaoli-Roach AA (1994). Isoform differences in substrate recognition by glycogen synthase kinases 3 alpha and 3 beta in the phosphorylation of phosphatase inhibitor 2. Biochemistry 33: 143–147.
  CAS PubMed Google Scholar
• Warner-Schmidt JL, Duman RS (2007). VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci USA 104: 4647–4652.
  CAS PubMed PubMed Central Google Scholar
• Watcharasit P, Bijur GN, Zmijewski JW, Song L, Zmijewska A, Chen X et al (2002). Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage. Proc Natl Acad Sci USA 99: 7951–7955.
  CAS PubMed PubMed Central Google Scholar
• Werstuck GH, Kim AJ, Brenstrum T, Ohnmacht SA, Panna E, Capretta A (2004). Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds. Bioorg Med Chem Lett 14: 5465–5467.
  CAS PubMed Google Scholar
• Wexler EM, Geschwind DH, Palmer TD (2008). Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 13: 285–292.
  CAS PubMed Google Scholar
• Woodgett JR (1990). Molecular cloning and expression of glycogen synthase kinase-3/factor A. Embo J 9: 2431–2438.
  CAS PubMed PubMed Central Google Scholar
• Yang ES, Wang H, Jiang G, Nowsheen S, Fu A, Hallahan DE et al (2009). Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice. J Clin Invest 119: 1124–1135.
  CAS PubMed PubMed Central Google Scholar
• Yao HB, Shaw PC, Wong CC, Wan DC (2002). Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J Chem Neuroanat 23: 291–297.
  CAS PubMed Google Scholar
• Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM (2009). The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14: 51–59.
  CAS PubMed Google Scholar
• Yuskaitis CJ, Jope RS (2009). Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21: 264–273.
  CAS PubMed Google Scholar
• Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS (2003). Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium Evidence for autoregulation of GSK-3. J Biol Chem 278: 33067–33077.
  CAS PubMed Google Scholar
• Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB et al (2005). Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45: 11–16.
  CAS PubMed Google Scholar